Statistical flag only — not an accusation of fraud
⚠️ This provider averages 2.0K services per working day — physically unusual for an individual practitioner
Based on 4.9M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $58.7M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 2.0K services per working day raises questions about billing patterns.
This provider has been statistically flagged with a risk score of 72/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $43.79 | $10.99 | 3.98x | $32.80 | $5.0M | 450.7K | 73 |
| 2015 | $50.85 | $13.65 | 3.73x | $37.20 | $5.5M | 406.1K | 72 |
| 2016 | $46.36 | $12.89 | 3.60x | $33.47 | $5.5M | 428.4K | 66 |
| 2017 | $61.03 | $15.11 | 4.04x | $45.92 | $5.4M | 354.3K | 67 |
| 2018 | $45.06 | $10.25 | 4.40x | $34.81 | $5.5M | 537.5K | 80 |
| 2019 | $48.55 | $12.16 | 3.99x | $36.39 | $8.1M | 667.9K | 77 |
| 2020 | $44.99 | $11.13 | 4.04x | $33.86 | $6.3M | 570.2K | 72 |
| 2021 | $46.88 | $11.23 | 4.17x | $35.65 | $5.3M | 473.8K | 66 |
| 2022 | $46.63 | $11.39 | 4.09x | $35.24 | $6.3M | 554.3K | 68 |
| 2023 | $50.63 | $12.54 | 4.04x | $38.09 | $5.7M | 453.8K | 65 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9035 | Injection, bevacizumab, 10 mg | 150.7K | $8.4M | $55.91 | 2.38x |
| J9299 | Injection, nivolumab, 1 mg | 323.1K | $7.2M | $22.38 | 2.93x |
| J9271 | Injection, pembrolizumab, 1 mg | 143.4K | $5.9M | $41.30 | 2.87x |
| J2505 | Injection, pegfilgrastim, 6 mg | 1.5K | $4.7M | $3.1K | 2.88x |
| J9310 | Injection, rituximab, 100 mg | 6.2K | $3.7M | $604.70 | 2.25x |
| J0897 | Injection, denosumab, 1 mg | 159.0K | $2.4M | $14.84 | 2.91x |
| J9022 | Injection, atezolizumab, 10 mg | 34.9K | $2.2M | $62.90 | 2.96x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 180.2K | $1.5M | $8.43 | 3.40x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 18.4K | $1.5M | $80.87 | 3.74x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 167.2K | $1.5M | $8.72 | 4.17x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 15.0K | $1.4M | $94.49 | 7.72x |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 30.2K | $1.3M | $41.73 | 4.05x |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 23.1K | $1.1M | $49.43 | 4.27x |
| J9312 | Injection, rituximab, 10 mg | 15.3K | $1.1M | $74.12 | 2.95x |
| J9041 | Injection, bortezomib, 0.1 mg | 36.9K | $1.1M | $29.69 | 3.72x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 20.0K | $1.0M | $50.13 | 3.95x |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 9.5K | $785.3K | $82.84 | 2.75x |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 20.0K | $695.3K | $34.82 | 4.84x |
| J1453 | Injection, fosaprepitant, 1 mg | 522.5K | $617.9K | $1.18 | 11.03x |
| 96375 | Injection of additional new drug or substance into vein | 38.1K | $516.0K | $13.55 | 8.70x |
This provider submits charges 4.01 times higher than what Medicare actually pays.
A markup ratio of 4.01x means for every $100 Medicare pays, this provider initially charges $401. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in AR for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Balagopalan Nair, M.D. | Little Rock, AR | $54.5M | ⚠️ Flagged |
| Eric Schaefer, M.D. | Fayetteville, AR | $35.5M | ✓ Clear |
| Thomas Sneed, M.D. | Little Rock, AR | $34.7M | ✓ Clear |
| Lawrence Mendelsohn, MD | Little Rock, AR | $34.6M | ⚠️ Flagged |
| Gregory Oakhill, M.D. | Fayetteville, AR | $34.2M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data